With 16 IDEs Approved, FDA Still Questions Artificial Pancreas Study Designs
This article was originally published in The Gray Sheet
Executive Summary
Since 2003, FDA has approved 16 investigational device exemptions for companies to begin trials on "artificial pancreas" devices, yet the agency is questioning what constitutes an appropriate study design for the products.
You may also be interested in...
Diabetes Researchers Say FDA Is Slowing Artificial Pancreas Efforts
Developers of "artificial pancreas" devices for treating type 1 diabetes may gain insight from new FDA draft guidance on clinical trial design, but patients and advocates say the agency is standing in the way of greater advances in the space.
Diabetes Researchers Say FDA Is Slowing Artificial Pancreas Efforts
The U.S. is "desperately behind the curve," as a "result of regulatory policy that is just not working in the interest of people who live with type 1 diabetes," JDRF CEO says.
Diabetes Researchers Say FDA Is Slowing Artificial Pancreas Efforts
Developers of "artificial pancreas" devices for treating type 1 diabetes may gain insight from new FDA draft guidance on clinical trial design, but patients and advocates say the agency is standing in the way of greater advances in the space.